A structural comparison between the KBTBD4–UM171–LHC complex and the two LHC-bound KBTBD4 MB mutants reveals a notable convergent mechanism by which the molecular glue and the cancer mutations complement and optimize the suboptimal protein–protein interface between the E3 ligase and HDAC1 to drive their association. Here, KBTBD4 is linked to cancer.